AzTrials
AzTrials

Gait Disorders, NeurologicNCT06442982

Analyzing Gait Pattern Using Insole-type Gait Analyzer in Patient With Gait Disturbance

A study testing insole-type gait analyzer in people with Gait Disorders, Neurologic, run by Yonsei University at 1 site in South Korea.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to explore the usefulness of information from insole-type gait analyzer in adults with subjective gait and balance disorders. The main questions it aims to answer are: How useful is an insole-type gait analyzer for collecting gait data from patients with gait disturbances?… Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Gait Disorders, Neurologic
What is being tested?
insole-type gait analyzer
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
1 siteSouth Korea
Study dates
1 Jun 2021to 31 May 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adults aged 19 and over (based on the age on their national ID at the time of consent)
  • adults complaining subjective gait or balance disorders
  • individuals who voluntarily agree to participate in the study and sign a consent form

Who cannot join

  • individuals unable to walk independently on flat ground for more than 6 minutes
  • individuals who cannot read ordinary print with glasses due to visual reasons
  • individuals who cannot understand conversation even with a hearing aid due to auditory reasons
  • individuals with clinically significant disorders in the cardiovascular, gastrointestinal, respiratory, or endocrine systems
  • individuals considered clinically unsuitable for the trial by the trial manager or person in charge based on significant medical findings.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Na Young Kim, MD, PhD contact

+82 010 9127 4482

kny8452@yuhs.ac

Seung Ick Choi contact

+82 010 8821 5297

rehab1@yuhs.ac

South Korea1 site, 1 recruiting
  • Yongin Severance Hospital

    Yongin-si, Gyeonggi-do, 16995

    Na Young Kim, +82 010 9127 4482, kny8452@yuhs.ac

    Seung Ick Choi, +82 010 8821 5297, rehab1@yuhs.ac

    Recruiting

Other trials in South Korea

About this study

Official title: Usefulness of Insole-type Gait Analyzer in Collecting Gait Data From Patients With Gait Disturbance

The goal of this clinical trial is to explore the usefulness of information from insole-type gait analyzer in adults with subjective gait and balance disorders.

The main questions it aims to answer are:

How useful is an insole-type gait analyzer for collecting gait data from patients with gait disturbances?

Researchers will explore the usefulness of collected data and does not establish a control group.

Participants will:

Participants will conduct survey and perform the Timed up and go test wearing an insole-type gait analyzer.

Read the detailed description

A screening test is conducted after obtaining consent. The screening test assesses whether participants can walk independently on flat ground, following an inquiry into their baseline symptoms and signs.

Participants will conduct A history survey, a sarcopenia questionnaire, and the International Physical Activity Questionnaire (IPAQ).

Participants will wear insole-type gait analyzer and undergo the Timed Up and Go test.

The measurement values of the accelerometer and pressure sensors recorded in the insole-type gait analyzer will be examined to determine the presence of missing or outlier data. Researchers will explore the data collection frequency and analysis methods to extract clinically significant data.

Being tested
insole-type gait analyzer
Keywords
gait analysis, smart insole, neurologic disorder
Medical subject headings
Gait Disorders, Neurologic, Nervous System Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • insole-type gait analyzerDevice

    Patients with subjective gait and balance disorders will wear insole-type gait analyzer and walk, then the collected data will be examined.

Study groups in NCT06442982
Study groupRoleWhat they receive
Insole wearing groupExperimentalPatients with subjective gait and balance disorders will wear insole-type gait analyzer and walk, then the collected data will be examined."
Receives: Device: insole-type gait analyzer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timed up and go test (TUG)

    The participants will wear insole-type gait analyzer and undergo the Timed Up and Go test.

    The above test assesses walking speed along with balance ability during walking, and this is performed as follows.

    1. A 46 cm high armrest chair, a color cone is placed at a distance of 3 meters from the chair and the subject is instructed to sit on the chair.
    2. In the preparation phase, the subject leans against the chair backrest and places his/her arms on the armrests, then stands up on the instruction "Start", walks 3 meters, turns around the color cone, returns to the starting point and sits down on the chair.
    3. Data Verification The measurement values of the accelerometer and pressure sensors recorded in the insole-type gait analyzer will be examined to determine the presence of missing or outlier data. The investigators will explore the data collection frequency and analysis methods to extract clinically significant data.

    Measured: TUG test session will last approximately 5 minutes. and TUG test will be performed at baseline.

  2. Korean version of Sarcopenia Screening Questionnaire

    Questionnaire that evaluates the decrease in muscle strength and functional performance along with a decrease in muscle mass and it is highly related to aging and chronic diseases. The evaluation method is conducted by having the examiner ask the subject about the following questionnaire, and the scores for the answers are recorded.

    It consists of 5 questions, and each question is scored 0-2 points. The higher the score, the higher the risk of sarcopenia. If the score is 4 or higher, sarcopenia may be suspected.

    Measured: This K-SSQ session will last approximately 1 minutes, it will be performed at baseline.

  3. Korean version of the International Physical Activity Questionnaire (K-IPAQ)

    Tests that assess various aspects of an individual's daily physical activity16 and it can provide information about activity level. The examiner questions the subject based on the questionnaire below, records related information, calculates the total activity time and intensity, and classifies it as 'low', 'medium', and 'high'.

    Measured: This K-IPAQ session will last approximately 3 minutes, it will be performed at baseline.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2024
  2. Study start1 Jun 2021
  3. Primary completion31 May 2025 (estimated)
  4. Study completion31 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Model description
This study aims to explore the usefulness of collected data and does not establish a control group. Patients with subjective gait and balance disorders will wear insole-type gait analyzer and walk, then the collected data will be examined."
Masking
None (open label)
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06442982
Sponsor's protocol ID
9-2021-0055
Status last verified
Feb 2025
First submitted
21 May 2024
Last updated
10 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Alexander NB. Differential diagnosis of gait disorders in older adults. Clin Geriatr Med. 1996 Nov;12(4):689-703.

    PubMed 8890111
  • Tinetti ME. Clinical practice. Preventing falls in elderly persons. N Engl J Med. 2003 Jan 2;348(1):42-9. doi: 10.1056/NEJMcp020719. No abstract available.

    PubMed 12510042
  • Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996 Jan 11;334(2):71-6. doi: 10.1056/NEJM199601113340202.

    PubMed 8531961
  • Salzman B. Gait and balance disorders in older adults. Am Fam Physician. 2010 Jul 1;82(1):61-8.

    PubMed 20590073
  • Verghese J, LeValley A, Hall CB, Katz MJ, Ambrose AF, Lipton RB. Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc. 2006 Feb;54(2):255-61. doi: 10.1111/j.1532-5415.2005.00580.x.

    PubMed 16460376
  • Fortin C, Feldman DE, Cheriet F, Labelle H. Clinical methods for quantifying body segment posture: a literature review. Disabil Rehabil. 2011;33(5):367-83. doi: 10.3109/09638288.2010.492066. Epub 2010 Jun 23.

    PubMed 20568973
  • Kim H, Lee S, Lee D, Choi S, Ju J, Myung H. Real-time human pose estimation and gesture recognition from depth images using superpixels and SVM classifier. Sensors (Basel). 2015 May 26;15(6):12410-27. doi: 10.3390/s150612410.

    PubMed 26016921
  • Chun MY. Validity and reliability of korean version of international physical activity questionnaire short form in the elderly. Korean J Fam Med. 2012 May;33(3):144-51. doi: 10.4082/kjfm.2012.33.3.144. Epub 2012 May 24.

    PubMed 22787536

Questions about this trial

What is this clinical trial studying?

A study testing insole-type gait analyzer in people with Gait Disorders, Neurologic, run by Yonsei University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Na Young Kim, MD, PhD (+82 010 9127 4482, kny8452@yuhs.ac), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timed up and go test (TUG) (time frame: TUG test session will last approximately 5 minutes. and TUG test will be performed at baseline.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06442982, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in